Pfizer, Allergan Set To Unveil $150 Billion Inversion

By | November 23, 2015

Scalper1 News

Pfizer (PFE) will announce a takeover Monday morning to buy Botox maker Allergan (AGN) for more than $150 billion, according to multiple reports. That would make it the biggest tax inversion deal in history. Pfizer’s board signed off the deal Sunday, reports said, with a Monday announcement planned. Pfizer will pay 11.3 shares plus a small cash component for each share of Allergan. The stock element alone would be worth $363.63 per share. Reports Scalper1 News

Scalper1 News